FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates 
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit 
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide 
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year 
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal 
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions 
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed 
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains 
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms 
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand 
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan 
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks 
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act 
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes 
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports 
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims 
SAN FRANCISCO, April 10, 2018 -- Vascular access technology innovator Velano Vascular today announced that company leadership will present at a number of premier healthcare conferences in the second quarter.
Chief Executive Officer Eric M. Stone will moderate a discussion entitled “Innovation and the Four Pillars of Healthcare Progress” at Becker’s Hospital Review 9th Annual Meeting on Thursday, April 12th. Panelists include Patrick Charmel, President and CEO of Griffin Hospital; Kim Henrichsen, RN, MSN, SVP Clinical Operations and Chief Nursing Executive at Intermountain Healthcare; Chris Waugh, Chief Innovation Officer at Sutter Health; and Joan Zoltanski, MD, Chief Experience Officer, University Hospitals Health System.
Stone will also participate in the panel discussion “Strategic Investors Make or Break Us” at HLTH: The Future of Healthcare on Sunday, May 6th in Las Vegas, NV. This conversation will explore the role that strategic investors play in the new healthcare innovation model.
Chief Medical Officer Pitou Devgon, MD will join a panel discussion at The Patient Experience Symposium on Tuesday, May 8th entitled “Engaging Practitioners in Patient Experience Innovation”. Devgon will be joined by Cheryl H. O’Malley DNP, NEA-BC, Vice President, Patient Care Services and Nursing at University Hospitals Cleveland Medical Center.
About Velano Vascular
Velano Vascular is a medical device innovator committed to reducing the pain, risk and inefficiencies of traditional blood collection practices while enhancing the clinical domain of vascular access. The company’s revolutionary FDA-approved PIVO device expands the use of peripheral IV lines for frequent, high quality and needle free blood draws, aiming to deliver painless, compassionate care for hospital inpatients, a safer practice for caregivers, and a more financially responsible alternative for health systems. More information is available at www.velanovascular.com.
Press Contact:
Michael Azzano
Cosmo PR
[email protected]
415-596-1978
